Submission Details
| 510(k) Number | K223324 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 31, 2022 |
| Decision Date | December 29, 2022 |
| Days to Decision | 59 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K223324 is an FDA 510(k) clearance for the Total Bilirubin2, a Diazo Colorimetry, Bilirubin (Class II — Special Controls, product code CIG), submitted by Abbott Ireland Diagnostics Division (Longsford, IE). The FDA issued a Cleared decision on December 29, 2022, 59 days after receiving the submission on October 31, 2022. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1110.
| 510(k) Number | K223324 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 31, 2022 |
| Decision Date | December 29, 2022 |
| Days to Decision | 59 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | CIG — Diazo Colorimetry, Bilirubin |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1110 |